7Q8-46365-67590
2 vaccinations
2 coded responses
14 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 191 / PA
- Registered
- 2021-02-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-14
Dose 1 — Pfizer-BioNTech
-
2021-02-08
Registered in v-safe
-
2021-02-08
Dose 2 — Pfizer-BioNTech
-
2021-02-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · Headache, Fatigue or tiredness, NauseaAdult check-in
- 2021-02-10
- 2021-02-11
- 2021-02-12
- 2021-02-13
- 2021-02-14
- 2021-02-22
- 2021-03-03
- 2021-03-08
- 2021-03-15
- 2021-03-22
- 2021-05-10
-
2021-08-09
Survey response — 6 months, dose 2MedDRA: Sinusitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Likely sinus infectionMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2022-02-08
Survey response — 12 months, dose 2MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: COVID-19MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-14 | Pfizer-BioNTech | |
| 2 | 2021-02-08 | Pfizer-BioNTech |
Free text
Release 9 — 6 months, dose 2
Symptoms: Likely sinus infection
Release 11 — 12 months, dose 2
Symptoms: COVID-19
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Sinusitis | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release